Table of contents
June 2006 Volume 3 No 6
Top of page
Editorial
Top of page
Viewpoint
Top of page
Research Highlights
LMWH therapy after mechanical heart valve replacement
292Risk factors predict survival and likelihood of cardiovascular events
292Noninvasive and long-term monitoring of pressure in abdominal aortic aneurysm sacs
292Dyslipidemia prevalence, treatment and control in a multiethnic population
293Percutaneous retrograde transarterial aortic valve implantation successful
293Is percutaneous heart valve replacement a feasible option for inoperable aortic stenosis?
294Key themes in reducing door-to-balloon times in patients with STEMI
294Brain natriuretic peptide is a marker of diastolic wall stress in heart failure
295Prehypertension and cardiovascular disease in high-risk individuals: the ARIC study
295Cangrelor inhibits platelet activation in patients undergoing PCI
295Rotterdam Study confirms that many myocardial infarctions are clinically unrecognized
296Are patients with rheumatoid arthritis prone to accelerated atherosclerosis?
296Optimum duration of clopidogrel pretreatment before PCI
297Top of page
Practice Points
Is antiplatelet therapy safe after intracerebral hemorrhage?
298How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?
300Does neuroprotection with NXY-059 improve patient outcome after acute ischemic stroke?
302Can dobutamine stress echocardiography predict patient outcome after acute myocardial infarction?
304Top of page
Reviews
Infective endocarditis: diagnosis and management
310doi:10.1038/ncpcardio0535 | Full Text | PDF (190K)
Technology Insight: clinical role of magnetic resonance angiography in the diagnosis and management of renal artery stenosis
329doi:10.1038/ncpcardio0556 | Full Text | PDF (337K)
Top of page
Case Study
Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis
339doi:10.1038/ncpcardio0576 | Full Text | PDF (224K)
